Evidence for systems that carry regulated work.
Source-backed reporting and analysis connected to the companies, capabilities, authorities, and operating domains it affects.
For computer and related systems used in finished-pharmaceutical CGMP operations, 21 CFR 211.68 requires accuracy checks on input and output and bases their degree and frequency on system complexity and reliability. A validated system label does not replace the written, executed, and exception-aware verification record.
FDA's September 25 update classified the Imager II Angiographic Catheter action as a Class I recall without changing the affected products or recommendations. The underlying August instructions require facilities to search both inner-pouch and outer-carton UPNs, then report actual individual units rather than cartons or five-packs.
The European Commission's revised Annex 19 becomes applicable on September 24, 2026. Its parallel-import, distribution, and trade section distinguishes packaging-material samples from one retention sample of each re-packaged finished-product operation, and allows a photographic or digital substitute only under a justified advance agreement with the competent authority. A digital image is not a default waiver of a physical sample.
SOLABS describes collaborative Microsoft Word editing through Office Online and SharePoint, automated comparison between revisions, and conversion of Word and Excel files into controlled PDF outputs. A regulated document needs a reproducible chain from the exact editable source through approval, rendering, metadata, release, and later retrieval; live collaboration alone does not identify the effective record.
Qualityze presents calibration records and visible asset status as part of its connected life-sciences QMS. A current calibration status can support equipment control, but it does not establish that the correct instrument, method, range, location, and product-specific conditions were acceptable for a particular regulated use.
LORENZ says its RIM platform centralizes administration while allowing organizations to customize who can view, edit, or manage regulatory information. A permission is defensible only when it is bound to the regulated object, product, market, action, lifecycle state, purpose, and effective period it actually authorizes.
Rimsys presents regulatory intelligence, product data, approvals, submissions, UDI, and change management as a connected regulatory information environment for medtech. Connection can speed impact analysis, but a new signal or proposed change should not silently rewrite the product and registration state that was actually approved.
Greenlight Guru presents a medical-device platform connecting design controls, risk, product traceability, documents, training, suppliers, quality events, and CAPA. Linked evidence can make a release review reconstructable, but the links do not establish that requirements were met or authorize a device to move forward.
ISO's current record defines a medical-device quality-management-system standard for organizations across the lifecycle. It does not certify an application or make a configured workflow conforming by itself.
Articles 83 through 86 connect device-lifecycle surveillance, technical documentation, corrective action, and class-specific reporting instead of leaving post-market data in a separate complaint archive.
The transition moves actor, device, certificate, and market-surveillance records from voluntary use into required EU operating workflows, increasing the cost of disconnected regulatory data.
